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Nonmuscle caldesmon from bovine brain bound to microtubul¢s with a stoichiometry of five tubulin darners to one molecule of caldcsmon with 
values of g~ 4.5×10 s M -t. The hindin~ of caldesmon to microtubules was inhibited in the presence of Ca 2. and calmodulin. The phosphorylation 
of caldcsmon by ¢dc2 kinase also eliminated the microtubule-binding activity. These results suggest that ca d¢ mon may play a physiological role 
in the functions ofmicrotubules. 
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1. INTRODUCTION 
Caldesmon is an actin-binding protein that regulates 
the act in-myosin interaction by a CaV~-calmodulin sys- 
tem in smooth muscle cells ([1] for review) and non- 
muscle cells [2]. It has been detected in a variety of  
vertebrate cells, having an apparent molecular weight 
on SDS-PAOE of  about 80 kDa in nonmusele cells and 
about 150 kDa in smooth muscle ce, lls [I]. The actin- 
binding activity ofcaldesmon is affected not only by the 
Ca2*-calmodulin system but also by the phosphoryla-  
tion with cdc2 kinase [3,4]. Caldesmon also binds di- 
rectly to tropomyosin [5-7] and to myosin [8,9]. How-  
ever, there are no reports about  the interaction of  cal- 
desmon with microtubules. 
In this study, we demonstrate a novel property of  
nonmuscle caldesmon: it can act as a microtubule asso- 
ciated protein that is regulated both by the Ca"*-calmo- 
dulin system and by phosphorylat ion with cdc2 kinase. 
2. MATERIALS  AND METHODS 
2.1 Proteins 
Nonmu..~l¢ caldesmon, 80 kDa on SDS-PAGE and 60 kDa from 
deduced amino acid sequence of DNA [1], was purifi~ from bovine 
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brain by the methods of Yamashiro.Matsumura et al. [10] and used 
as nonmuscle caldesmon. Tubulin was purified from porcine brain by 
the method of Shelanski et al. [11] and used as microtubule after 
polymerization. Human edc2 kinas¢ that was partially purified from 
HeLa c¢lls [4] and monoclonal antibody that was raised against 
smooth muscle caldesmon as designated SMI2 [10] were generously 
provided by Dr. Fumio Matsumura (Rutgers University, N J, USA). 
Calmodulin from bovine brain was purchased from Sigma (St. Louis, 
Me, USA). 
2.2. Assay for bonding to microtubules 
Taxol-stabilized microtubules (10/aM) were mixed with various 
concentrations of nonmusele caldesmon (0-8/aM) in 100 mM MES 
(pH 6.8), 1 mM GTP, 1 mM DTT, I mM MgCi_~, and 15 mM KCI 
and then incubated for 30 man at room temperature. The mixtures 
were centrifuged in an airfug¢ (Beckman, Pale Alto, CA, USA) at 
140,000 × g for 20 man. The amounts of he proteins in suparnatants 
and pellets were analyzed by SDS-PAGE and quantitated by densi- 
tometry (Joyee Loebl, Malden, MA, USA). 
2.3. Phosphorylation f caldesmon by cde2 kinase 
Nonmuscle caldesmon (2.5/aM) was incubated with erie2 kinase at 
30°C for 40 man in 10 mM MgCI2, 0.2 mM EGTA, 1 mM DTT, 10 
/zg/ml chymostatin, 10/zg/ml leupcptin and 10/ag/ml pcpstatin in the 
presence or absence of 1 mM ATP containing 200 mCi/mmol [?- 
3=P]ATP (Amersham, Buckingham, UK). Reactions were terminated 
by boiling the mixtures for 10 man, and the mixtures were then cen- 
trifuged at 14,000 × g for 10 man. Supernatants were used a  phosphor- 
ylated ealdesmon and control caldesmon, respectively. 
2.4. Other procedures 
Protein concentrations were determined by the methods of Lowry 
et al. [12], with bovine serum albumin as a standard, gD$-PAGE was 
performed as described previously [13]. Western blots wer~ l~rformed 
according to the methods ofTowbin et al. [14]. 
3. RESULTS 
3,1, Binding of nonmuscle caldesmon to microtubules 
We subjected a crude fraction of  microtubules to 
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Fig. 2. Nonmuscle caldesmon (CAD) from bovine brain binds to mi- 
crotubal~s. Microtubules were mixed CaD, and then the mixtures 
were centrifuged at 140,000 x g for 20 rain. Supernatants and pellets 
were subjected to SDS-PAGE and the amounts of CaD and tubulln 
were determined by densitometry. Ordinate: molar ratio of the 
amount of nonmuscle caldesmon that co.sedhnent~ with micro. 
tubules. Abscissa: the concentration f nonmuscle caldesmoa that was 
mixed with microtubules. 
Fig. I. A crude fraction of microtubules from bovine brain contains 
150 kDa and 80 kDa peptides that cross-react with an antibody raised 
against smooth muscle caldesmon. Bovine brain was homogenized 
with 0.8 volumes of 100 mM MES (pH 6.8), 0.5 mM MgCI 2, 1 mM 
EGTA and 1 mM GTP, and the homogeaate was centrnfuged at 
12,000 xg  for 10 rain. The supernatant was incubated at 37°C for 30 
rain to polymerize the tubulin and then centrif,ged at 100,000 xg  for 
1 h. The pellet was used as the crude microtubule fraction. The crude 
microtubule fraction (30/zg) was analyzed by SDS-PAGE and blotted. 
(Lane 1) Amido black staining; (lane 2) corresponding immunoblot 
stained with a caldesmon-specific antibody. 
analysis by Western blotting using an antibody raised 
against smooth muscle caldesmon. As shown in Fig. 1, 
150 kDa and 80 kDa polypeptides cross-reacted with 
the antibody. The molecular weigilts of these peptides 
were identical to those of brain caldesmons [15]~ indicat- 
ing that brain caldesmons are co-purified with micro- 
tubules. 
To confirm whether brain caldesmons belong to the 
family of proteins that are associated with micro- 
tubules, we examined the binding of caldesmon to mi- 
crotubules in vitro. As shown in Fig. 2, the amount of 
nonmuscle caldesmon that bound to microtubules 
gradually increased as the concentration of caldesmon 
was increased. The binding constant was 4.5 x 10 s M "t. 
The binding was saturated at a stoichiometry of non- 
muscle caldesmon to tubulin dimers of 0.18:1, if we 
assume the molecular weight of  the tubulin dimers and 
nonmuscle caldesmon are 100 kDa [16] and 60 kDa [1], 
respectively. 
3.2. Regulation by Ca2÷-calrnodulin of the microtubule. 
binding activity of nonmuscle caldesmon 
When we mixed microtubules with nonmusole cal- 
desmon and calmodulin in the presence of EGTA, 56% 
of the caldesmon bound to the microtubules (Fig. 3, 
lane 2), a level similar to that observed in the absence 
of calraodulin. By contrast, only 3% of the caldesmon 
bound to microtubules in the presence of Ca 2" (Fig. 3, 
lane 4). These results suggest that the binding activity 
of caldesmon to microtubules i  inhibited by the Ca 2*- 
calmodulin system. 
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Fig. 3. The binding of nonma,sole ¢aldcsmon (CAD) to microlubulcs 
is inhibited in the presence of Ca 2÷ and galmoduUn (CAM). Taxol- 
stabilized microtubules (10#M) were incubated with 1.6/zM CaD and 
10/zM CaM in the presence of EGTA or CA2, and then mixtures were 
14~t~J0  X ~ tOf  2U t | i l ] t .  • tt~. SUl,nDt ~ ,  an~ I t~ .~ "l~ *, ~re  ocntrif,8cd at . . . . . . " . . . . . . .  .,.de . . . .  
separ'_ted end analyzed by SDS-PAGE. (Lanes I and 2) Snpenmtant 
and pellet, respectively, obtained with !mM EGTA; (lan~ 3 and 4) 
supernatant and pellet, respectively, obtained with 0.1 mM CA=*. 
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Fig. 4. Phosphorylation of nonmusele ealdesmon (CAD) by ode2 
kinase inhibits the microtubule-bindin 8 activity of ealdesmon. CaD 
was phosphorylated by human cdc2 kinase with [?'-UP]ATP. As a 
control, CaD was incubated with edc2 kinase in the absence of ATP, 
The control and phosphorylated caldesmons (1.6/zM) were mixed 
with 10/2M microtubules. Mixtures were centrifuged at 140,000 × g 
for 20 rain and subjected to SDS.PAOE, (Lanes 1 and 2) Staining with 
Coomassie blue of Sul~rnatant and pellet, respectively, obtained with 
the phosphorylated caldesmon; (lanes 3 and4) staining with Coomas. 
sic blue of Sul~rnatant and precipitate, respectivdy, obtained with the 
control caldesmon; (lanes 5-8) autoradiography corresponding to
lanes 1-4, 
3.3. Effects of phosphorylation f nonmuscle caldesmon 
on the binding of caldesrnon to microtubules 
We examined the effects of phosphorylation bycdc2 
kinase on the binding of nonmuscle caldesmon to mi- 
crotubules. Nonmuscle caldesmon was phosphorylated 
by cdc2 kinase, and then the phosphorylated caldesmon 
was mixed with microtubules and pelleted with the mi- 
crotubules by centrifugation. As shown in Fig. 4, 50% 
of the control caldesmon bound to microtubules (lane 
2) while only 4% of the phosphorylated caldesmon 
bound to microtubules (lane 4). These results suggest 
that phosphorylation of caldesmon by cdc2 kinase 
causes nonmuscle aldesmon to dissociate from micro. 
tubules. 
4. DISCUSSION 
The present study shows that nonmuscle caldesmon 
has microtubule-binding activity in vitro. We are confi- 
dent that this activity is an inherent property of native 
caldesmon because it is subject to physiological ways of 
control such as Ca2"-calmodulin system ([I 7] for review) 
and phosphorylation by cdc2 kinase ([18] for review). 
There are some indications of interactions between 
actin filaments and microtubules in rive. For example, 
the disruption of actin networks by cytochal~sin D in- 
hibits the motility of controsomes in human leukocytes 
[19]. MAP2 is suggested to be a cross-linker between 
microtubules and actin filaments because MAP2 can 
bind both to microtubules and to actin filaments in vitro 
[20,21]. Thus, it is provable that nonmuscle caldesmon 
may also work as a microtubule-associated protein to 
cross-link between microtubules and actin filaments. 
However, the immunofluoresconco studies with non- 
muscle coils show that caldesmon is detectable in as- 
sociation with actin filaments but not with microtubules 
[1]. At this point, we do not know the reason of the 
disagreement of the studies with the present results in 
vitro. Further characterization of the microtubule-bind- 
ing activity of caldesmon both in situ and in vitro 
remains to be demonstrated. 
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